Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 229

1.

Neonatal abstinence syndrome: treatment and pediatric outcomes.

Logan BA, Brown MS, Hayes MJ.

Clin Obstet Gynecol. 2013 Mar;56(1):186-92. doi: 10.1097/GRF.0b013e31827feea4. Review.

2.

The effect of prenatal alcohol co-exposure on neonatal abstinence syndrome in infants born to mothers in opioid maintenance treatment.

Kreitinger C, Gutierrez H, Hamidovic A, Schmitt C, Sarangarm P, Rayburn WF, Leeman L, Bakhireva LN.

J Matern Fetal Neonatal Med. 2016 Mar;29(5):783-8. doi: 10.3109/14767058.2015.1018168. Epub 2015 Mar 23.

3.

Neonatal abstinence syndrome.

Jansson LM, Velez M.

Curr Opin Pediatr. 2012 Apr;24(2):252-8. doi: 10.1097/MOP.0b013e32834fdc3a. Review.

PMID:
22227786
4.

Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison.

Unger A, Jagsch R, Jones H, Arria A, Leitich H, Rohrmeister K, Aschauer C, Winklbaur B, Bäwert A, Fischer G.

Addiction. 2011 Jul;106(7):1355-62. doi: 10.1111/j.1360-0443.2011.03440.x. Epub 2011 May 12.

5.

Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and meta-analysis.

Brogly SB, Saia KA, Walley AY, Du HM, Sebastiani P.

Am J Epidemiol. 2014 Oct 1;180(7):673-86. doi: 10.1093/aje/kwu190. Epub 2014 Aug 22. Review.

PMID:
25150272
6.

Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy.

O'Connor AB, Collett A, Alto WA, O'Brien LM.

J Midwifery Womens Health. 2013 Jul-Aug;58(4):383-8. doi: 10.1111/jmwh.12009.

PMID:
23931660
7.

Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome.

Gray TR, Choo RE, Concheiro M, Williams E, Elko A, Jansson LM, Jones HE, Huestis MA.

Addiction. 2010 Dec;105(12):2151-9. doi: 10.1111/j.1360-0443.2010.03097.x. Epub 2010 Sep 20.

8.

Are there gender related differences in neonatal abstinence syndrome following exposure to buprenorphine during pregnancy?

O'Connor AB, O'Brien L, Alto WA.

J Perinat Med. 2013 Sep 1;41(5):621-3. doi: 10.1515/jpm-2012-0288.

PMID:
23612625
9.

Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study.

Bakstad B, Sarfi M, Welle-Strand GK, Ravndal E.

Eur Addict Res. 2009;15(3):128-34. doi: 10.1159/000210042. Epub 2009 Mar 31.

PMID:
19332991
10.

Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis.

Cleary BJ, Donnelly J, Strawbridge J, Gallagher PJ, Fahey T, Clarke M, Murphy DJ.

Addiction. 2010 Dec;105(12):2071-84. doi: 10.1111/j.1360-0443.2010.03120.x. Epub 2010 Sep 15. Review.

PMID:
20840198
11.

Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study.

Desai RJ, Huybrechts KF, Hernandez-Diaz S, Mogun H, Patorno E, Kaltenbach K, Kerzner LS, Bateman BT.

BMJ. 2015 May 14;350:h2102. doi: 10.1136/bmj.h2102.

12.

Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates.

Gaalema DE, Scott TL, Heil SH, Coyle MG, Kaltenbach K, Badger GJ, Arria AM, Stine SM, Martin PR, Jones HE.

Addiction. 2012 Nov;107 Suppl 1:53-62. doi: 10.1111/j.1360-0443.2012.04039.x.

13.

Maternal Substance Use and Neonatal Abstinence Syndrome: A Descriptive Study.

McQueen KA, Murphy-Oikonen J, Desaulniers L.

Matern Child Health J. 2015 Aug;19(8):1756-65. doi: 10.1007/s10995-015-1689-y.

PMID:
25656717
14.

Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources.

Dryden C, Young D, Hepburn M, Mactier H.

BJOG. 2009 Apr;116(5):665-71. doi: 10.1111/j.1471-0528.2008.02073.x. Epub 2009 Feb 10.

15.

Higher maternal doses of methadone does not increase neonatal abstinence syndrome.

Pizarro D, Habli M, Grier M, Bombrys A, Sibai B, Livingston J.

J Subst Abuse Treat. 2011 Apr;40(3):295-8. doi: 10.1016/j.jsat.2010.11.007. Epub 2011 Jan 20.

PMID:
21255960
16.

Methadone and perinatal outcomes: a prospective cohort study.

Cleary BJ, Eogan M, O'Connell MP, Fahey T, Gallagher PJ, Clarke T, White MJ, McDermott C, O'Sullivan A, Carmody D, Gleeson J, Murphy DJ.

Addiction. 2012 Aug;107(8):1482-92. doi: 10.1111/j.1360-0443.2012.03844.x. Epub 2012 May 8.

PMID:
22340442
17.

Perinatal risk factors for the neonatal abstinence syndrome in infants born to women on methadone maintenance therapy.

Liu AJ, Jones MP, Murray H, Cook CM, Nanan R.

Aust N Z J Obstet Gynaecol. 2010 Jun;50(3):253-8. doi: 10.1111/j.1479-828X.2010.01168.x.

PMID:
20618243
18.

Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome.

Pritham UA, Paul JA, Hayes MJ.

J Obstet Gynecol Neonatal Nurs. 2012 Mar;41(2):180-90. doi: 10.1111/j.1552-6909.2011.01330.x. Epub 2012 Feb 29.

19.

Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.

Winhusen T, Wilder C, Wexelblatt SL, Theobald J, Hall ES, Lewis D, Van Hook J, Marcotte M.

Contemp Clin Trials. 2014 Sep;39(1):158-65. doi: 10.1016/j.cct.2014.08.009. Epub 2014 Aug 23.

PMID:
25183042
20.

Managing opioid dependence in pregnancy -- a general practice perspective.

Arunogiri S, Foo L, Frei M, Lubman DI.

Aust Fam Physician. 2013 Oct;42(10):713-6. Review.

Supplemental Content

Support Center